Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors

Pauline Rettman(University of Southampton), Salim I. Khakoo(University Hospital Southampton NHS Foundation Trust)
Journal for ImmunoTherapy of Cancer
May 1, 2021
Cited by 18


Related Papers